Silver Book Fact

In one study, deep-brain stimulation for Parkinson’s patients significantly reduced their required dosages of antiparkinsonian medications, consequently decreasing their medication costs by 32% 1 year after surgery, and 39% 2 years after.

Charles P, Padaliya B, Newman W, Gill C, et al. Deep Brain Stimulation of the Subthalamic Nucleus Reduces Antiparkinsonian Medication Costs. Parkinsonism & Related Disorders. 2004; 10(8): 475-9. https://www.prd-journal.com/article/S1353-8020(04)00096-3/fulltext

Reference

Title
Deep Brain Stimulation of the Subthalamic Nucleus Reduces Antiparkinsonian Medication Costs
Publication
Parkinsonism & Related Disorders
Publication Date
2004
Authors
Charles P, Padaliya B, Newman W, Gill C, et al.
Volume & Issue
Volume 10, Issue 8
Pages
475-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money
     
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • Impact of Slowed Progression on Severe Stage, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
  • Out-of-Pocket Costs, Slowed Progression  
  • According to one Parkinson’s expert, a 10% slowing of Parkinson’s disease progression would save $327 million per year.